Navigation Links
Studies assess genetics, modified treatment to improve outcomes, reduce toxicity
Date:12/8/2012

l influences such as access to care or oral medication compliance. Of the 492 patients, 138 (28%) had the SNP rs16754 (SNP+). After stratifying the patients by ethnicity, the investigators found that the presence of SNP rs16754 varied by race, with 53 percent of Asians, 34 percent of Hispanics, 25 percent of Caucasians, and 21 percent of African Americans carrying the genetic variation. The SNP+ patients had higher five-year overall survival rates than those without the variation (SNP-) (61% vs. 44%). Within each racial subgroup, the five-year overall survival rate was higher in the SNP+ patients.

Although survival improvements in leukemia clinical trials are often attributed to increased remission rates or decreased relapse, remission and relapse rates did not differ significantly between SNP+ and SNP- patients in this study. The investigators examined whether the SNP had any association with TRM and found that TRM rates did not differ by SNP rs16754 genotype when all ethnicities were considered together. However, TRM rates in SNP+ African-American and Asian patients, when taken together, were significantly lower than in SNP- patients of those two ethnicities. African-American and Asian patients without SNP rs16754 had significantly higher rates of treatment-related toxic death compared to SNP+ patients (African-American: 25% vs. 0%; Asian: 43% vs. 0%). These results suggest that the protective effect of the presence of SNP rs16754 in reducing chemotherapy-related toxicity in pediatric AML patients is more pronounced in those of African-American and Asian descent.

"Identifying the patient-specific factors that can affect responses to treatment in different patients with the same disease brings us closer to our goal of designing personalized treatments that provide the most therapeutic benefit with the least amount of toxicity to these children," said Phoenix Ho, MD, lead author and Attending Physician at Seattle Children's Hospital in the Divisi
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. John Theurer Cancer Center to present 37 studies at the 2012 ASH Annual Meeting
2. Benefit6 Whole Body Protection, a New Product by I Do Strive LLC, Provides Increased Energy Production According to Recent Studies
3. Sharp spike in computer-related injuries predicted for medical workers, find studies
4. Analysis of conflicting fish oil studies finds that omega-3 fatty acids still matter
5. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
6. New studies show effects of mammography guideline changes
7. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
8. Scripps studies show community-based diabetes programs are key to lowered costs and improved care
9. Cancer Drug Reduced Relapses in MS Patients: Studies
10. University of Houston India Studies Program presents Circuits of Empire: India as Metropole
11. Studies Show Limits, Promise of Laser Removal of Tattoos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Va. (PRWEB) October 22, 2014 ... Innovation , which is dedicated to distribute health ... of healthcare delivery worldwide announced the development of ... which patients expect when receiving healthcare. These are ... for patient-centered care: “providing care that is respectful ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the most ... recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is the ... the world. , “iPower is one of the most ... various kinds of useful products for new and old ... customer service and a number of features which will ...
(Date:10/22/2014)... CA (PRWEB) October 22, 2014 Lintelus, ... Cormier, Sr. Vice President of Sales, will be speaking ... upcoming Meetings Technology Expo on October 28, at the ... be hosting a booth as well as a Tech ... Lintelus Meeting can create a more engaging event experience. ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter , ... in vitro fertilization (IVF) are only about half as likely ... reproduction technique, new research indicates, and the racial disparity persists ... about 31 percent of white patients became pregnant after IVF, ... more than 4,000 IVF cycles over two years to tease ...
(Date:10/22/2014)... News) -- Measures taken by Firestone officials at the ... have limited the spread of the disease there and ... Natural Rubber Co. provides health services to about 80,000 ... populated communities. Between Aug. 1 and Sept. 23, ... those 80,000 people. That incidence rate of 0.09 percent ...
Breaking Medicine News(10 mins):Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
... 6000(TM) and PulseOx 6100(TM) to be launched at MEDICA ... Medical Inc. (OTC,Bulletin Board: SPOM), a leading developer of ... today announced that,the PulseOx 6000(TM) and PulseOx 6100(TM), two ... at the 39th MEDICA World Forum for,Medicine in Dusseldorf, ...
... CHICAGO, Nov. 14 Health Care Service Corporation,(HCSC), ... plans in Illinois,New Mexico, Oklahoma and Texas, today ... Hemingway Hall as the company,s new president and,chief ... F. McCaskey,HCSC chief executive officer. Hemingway Hall ...
... Anthem Blue Cross and Blue, Shield provides funding to ... located in the eastern and western parts of the ... Cross and Blue,Shield today launched its new State Health ... and help address major health,issues in the state. Anthem ...
... - Parascript(R) AccuDetect(TM) to work with mammography systems ... to reduce industry problem of false-positives and ... -, BOULDER, Colo., Nov. 14 Parascript, ... today announced its,entrance into the medical imaging market. ...
... Sales Total $3.1 Million in Quarter; Amoxicillin PULSYS NDA ... Review Ongoing - PDUFA Date ... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical company ... and operational results for the quarter ended September,30, 2007. ...
... details CTI,s new cancer drug development platform, ... heard first-hand the progress and prospects of three ... and MTAX: CTIC) oncology drug,candidates, as well as ... this,year, from an international panel of clinical investigators ...
Cached Medicine News:Health News:SPO Medical Unveils New Oximetry Devices for European Markets 2Health News:SPO Medical Unveils New Oximetry Devices for European Markets 3Health News:Health Care Service Corporation Names New President and Chief Operating Officer 2Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 2Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 3Health News:Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index 4Health News:Parascript Enters Medical Imaging Breast Cancer Detection Market With Established Image Analysis Technology 2Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 2Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 4Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 5Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 6Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 7Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 8Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 9Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 10Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 11Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 12Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 13Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 14Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 2Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 3Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 4Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 5Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 6Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 7Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 8
(Date:10/22/2014)... Oct. 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: ... its novel investigational drug for cancer, is designed for ... side effects. Its oncology focus is on melanoma, breast ... phase 2 trials of PV-10 as a therapy for ... for atopic dermatitis and psoriasis. This ...
(Date:10/22/2014)... NORWALK, Conn. , Oct. 22, 2014  Recently ... (GERD) have bolstered the already substantial database of evidence. ... and adoption of Stretta therapy for sufferers ... of clinical evidence supporting Stretta therapy as ... coverage policies that make Stretta therapy available to nearly ...
(Date:10/22/2014)... SHANGHAI , Oct. 22, 2014   ... and WuXi PharmaTech (Cayman) Inc. (NYSE: WX ... comprehensive genomic profiling to biopharmaceutical companies conducting clinical trials ... Under the terms of the collaboration, Foundation Medicine will ... of Foundation Medicine,s FoundationOne® assay at the WuXi Genome ...
Breaking Medicine Technology:Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5
... March 31, 2011 Navinta,s proprietary complex pharmaceutical ingredient, ... 7,179,939 and US Drug Master File is a key ... for Sodium Ferric Gluconate Complex in Sucrose Injection, 62.5 ... complex pharmaceutical ingredient technology provides a platform for preparation ...
... N.C., March 31, 2011 Paul Meade, the president ... NC company focused on facilitating medical expert collaborations with ... invitation to speak at the annual meeting of the ... 20th Annual Meeting and Clinical Congress of the American ...
Cached Medicine Technology:Paul Meade Accepts Invitation to Speak at AACE Annual Meeting 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: